CD8A and neoplasm: In particular, CD8+ T cells can directly recognize and kill tumor cells: they identify complexes of tumor-specific antigens (TSAs) or tumor-associated antigens (TAAs) with MHC class I molecules on the surface of tumor cells via T cell receptors (TCRs).